News
The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about ...
A second patient with Duchenne muscular dystrophy has died from acute liver failure after receiving the gene therapy Elevidys ...
Shares of gene editing companies were largely steady in the premarket on Friday after the FDA’s Center for Biologics Research ...
Another patient has died from acute liver failure after receiving Sarepta’s gene therapy for DMD ; After a quiet start to the ...
4d
Stocktwits on MSNSarepta Pauses DMD Gene Therapy Trial After Second Death; Retail Traders Brush Off RiskRetail investor chatter around Sarepta Therapeutics surged on Sunday after the company announced it had suspended shipments ...
Sarepta Therapeutics ( NASDAQ: SRPT) fell ~38% in the premarket on Monday after the company reported a second fatality from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results